Trials / Completed
CompletedNCT02275468
Fu-zheng-qu-zhuo Oral Liquid Improves Renal Function in Patients of CKD Stage 3 and 4
Fu-zheng-qu-zhuo Oral Liquid Combined With Integrated Therapy Improves Renal Function in Patients of Chronic Kidney Disease Stage 3 and 4，a Randomized Placebo-Control Clinical Trial
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 124 (actual)
- Sponsor
- Guang'anmen Hospital of China Academy of Chinese Medical Sciences · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
a prospective, multicenter (outpatient clinics of the three participating hospitals in Beijing), double blinded and randomized placebo-controlled study. The study consisted of a 2-week run-in period and a 12-month treatment period.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Fu-zheng-qu-zhuo (FZQZ) oral liquid | FZQZ oral liquid is a herbal medicine, composed of astragalus, angelica root, rhubarb, etc, with the effect of reinforcing Qi and activating blood, dissolving dampness and downbearing turbid. |
Timeline
- Start date
- 2010-06-01
- Primary completion
- 2013-05-01
- Completion
- 2014-10-01
- First posted
- 2014-10-27
- Last updated
- 2014-10-27
Locations
3 sites across 1 country: China
Source: ClinicalTrials.gov record NCT02275468. Inclusion in this directory is not an endorsement.